Design Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DSGN and other ETFs, options, and stocks.About DSGN
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
DSGN Key Statistics
Stock Snapshot
As of today, Design Therapeutics(DSGN) shares are valued at $13.30. The company's market cap stands at 830.37M, with a P/E ratio of -11.14.
On 2026-05-02, Design Therapeutics(DSGN) stock traded between a low of $12.95 and a high of $13.94. Shares are currently priced at $13.30, which is +2.7% above the low and -4.6% below the high.
The Design Therapeutics(DSGN)'s current trading volume is 495.17K, compared to an average daily volume of 679K.
In the last year, Design Therapeutics(DSGN) shares hit a 52-week high of $17.25 and a 52-week low of $3.11.
In the last year, Design Therapeutics(DSGN) shares hit a 52-week high of $17.25 and a 52-week low of $3.11.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.